Floatz logo

Therapeutic Asset Ratings

125 results matching 1 filter

129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
Wokvac Vaccine
HER2 Positive Breast Carcinoma
H. Lee Moffitt Cancer Center and Research InstituteP2CCC (48)
Nelitolimod
HER2 Positive Breast Carcinoma
QuantumLeap Healthcare CollaborativeP2CC (46)
IMMUNOGLOBULIN G, ANTI-(HUMAN INSULIN-LIKE GROWTH FACTOR I RECEPTOR) (HUMAN MONOCLONAL HEAVY CHAIN), DISULFIDE WITH HUMAN MONOCLONAL LIGHT CHAIN, DIMER
HER2 Positive Breast Carcinoma
QuantumLeap Healthcare CollaborativeP2CC (45)
Immunoglobulin G1, anti-(human neuregulin receptor HER3) (human monoclonal U3-1287 heavy chain), disulfide with human monoclonal U3-1287 ?-chain, dimer
HER2 Positive Breast Carcinoma
QuantumLeap Healthcare CollaborativeP2CC (44)
Spartalizumab
HER2 Positive Breast Carcinoma
SOLTI Breast Cancer Research GroupP2CC (44)
bi-1607
HER2 Positive Breast Carcinoma
BioInvent International ABP1/2CC (41)
Dual-Target Car-Nk Cells
HER2 Positive Breast Carcinoma
Beijing BiotechP1/2CC (41)
Phesgo / / 20,000 Unt In
HER2-positive Breast Cancer
Hoffmann-La RocheP1/2CC (41)
sbt6050
HER2 Positive Breast Carcinoma
Silverback TherapeuticsP1/2CC (41)
Axitinib
HER2 Positive Breast Carcinoma
Lynkcell EuropeP1CC (40)
Amcenestrant
HER2 Positive Breast Carcinoma
QuantumLeap Healthcare CollaborativeP2C (39)
Elvn-002
HER2 Positive Breast Carcinoma
Enliven TherapeuticsP1C (37)
Evorpacept
HER2 Positive Breast Carcinoma
QuantumLeap Healthcare CollaborativeP1C (37)
her2bbζ/cd19t+ t cells
HER2 Positive Breast Carcinoma
H. Lee Moffitt Cancer Center and Research InstituteP1C (37)
her2 vaccine
HER2 Positive Breast Carcinoma
Pravin T.P KaumayaP1C (37)
MVF-HER-2 (266-296)
HER2 Positive Breast Carcinoma
Pravin T.P KaumayaP1C (37)
Orm-5029
HER2 Positive Breast Carcinoma
Orum Therapeutics USA, Inc.P1C (37)
Pepinemab
HER2 Positive Breast Carcinoma
H. Lee Moffitt Cancer Center and Research InstituteP1C (37)
Xmt-2056
HER2 Positive Breast Carcinoma
Day One Biopharmaceuticals, Inc.P1C (37)
Avelumab
HER2 Positive Breast Carcinoma
Royal Marsden NHS Foundation TrustP1C (36)
Omnipaque
HER2 Positive Breast Carcinoma
Alison StopeckEarly P1C (34)
99mTc-DARPinG3
HER2 Positive Breast Carcinoma
Tomsk National Research Medical Center of the Russian Academy of SciencesD (28)
Herombopag
HER2 Positive Breast Carcinoma
Zhenzhen LiuN/AD (28)
Trastuzumab Rezetecan
HER2 Positive Breast Carcinoma
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityD (28)
Thero2-01S22
HER2 Positive Breast Carcinoma
Institut de cancérologie Strasbourg EuropeP3NR (0)
Showing 101 to 125 of 125 assets
PreviousPage 5 of 5Next